Ania Jastreboff, director of the Yale Obesity Research Centre who has led key Mounjaro studies for Lilly, said at a conference that improving the quality — not just the quantity — of weight loss was an essential next-step.
Experts aren’t clear on just how big of a problem this is for older people taking diabetes and weight-loss drugs such as Mounjaro and Wegovy. In a clinical trial of semaglutide, researchers found that on average, people lost about 6.8 kilograms of lean muscle and 10.4 kilograms of fat during a 68-week trial. The average age in that group of people was 52.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: